Other Barks & Bites for Friday, September 16: IPWatchdog LIVE Takes Over Renaissance Richardson Dallas, Biden Issues Executive Order on Biotech Innovation, and EGC Affirms Ruling Against Google’s Android Restrictions

Bite (noun): more meaty news to sink your teeth into.

Bark (noun): peripheral noise worth your attention.

https://depositphotos.com/220243566/stock-photo-retriever-dog-cap-eyeglasses-holding.htmlThis week in Other Barks & Bites: IPWatchdog LIVE sees 250 top industry insiders partake in panel sessions and other events at the Renaissance Richardson Dallas hotel; GM announces a nearly $500 million investment into electric vehicle upgrades at a factory in Marion, IN; the European General Court affirms an EU Commission ruling finding that Google placed unlawful restrictions on manufacturers and network providers operating in the Android market; Senator Roger Wicker (R-MS) reintroduces a bill to codify name, image and likeness (NIL) rights for collegiate athletes; and President Biden issues an executive order directing several federal agencies to oversee $2 billion in funding for biotech and biomanufacturing R&D initiatives.


IPWatchdog LIVE 2022 Brings Together Top IP Industry Insiders in Dallas This Week – On Sunday, September 11, IPWatchdog kicked off the first day of its LIVE 2022 conference at the Renaissance Dallas Richardson Hotel with a fireside chat between IPWatchdog Founder and CEO Gene Quinn and USPTO Texas Regional Director Hope Shimabuku. That same day, former USPTO Director Andrei Iancu was presented with the second annual Paul Michel Award for contributions to the U.S. patent community. Other panel discussions at the three-day conference covered the path forward from American Axle, patent litigation in the Western District of Texas, and the future of patent policy at the USPTO.

CAFC Affirms Denial of Motions to Terminate Following SCOTUS Vacature in Arthrex – On Thursday, September 15, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Polaris Innovations Ltd. v. Brent in which the appellate court affirmed a Patent Trial and Appeal Board (PTAB) ruling finding all challenged claims of Polaris Innovations Limited’s patents unpatentable and denying Polaris’ motions to terminate.

EGC Affirms EU Commission’s Ruling that Google Imposed Unlawful Android Restrictions – On Wednesday, September 14, the European General Court (EGC) affirmed a July 2018 ruling by the European Commission finding that Internet services giant Google violated the EU’s competition laws by imposing anticompetitive contractual restrictions on mobile device manufacturers and mobile network operators to unlawfully maintain a market dominant position for Google’s search engine and app store.

CAFC Rules That Claim Amendments Doom SawStop’s PTA Lawsuits – On Wednesday, September 14, the Federal Circuit issued a precedential decision in SawStop Holding LLC v. Vidal in which the appellate court affirmed the Eastern District of Virginia’s summary judgment ruling denying patent term adjustments (PTAs) to patent owner SawStop. The Federal Circuit agreed with the district court that the appealed patents were not subject to a guaranteed PTA for delays in issuance caused by appeals because the original claims remained rejected by the Patent Trial and Appeal Board (PTAB) while SawStop sought extensions for claims that only issued after further prosecution and amendment.

Senator Wicker Reintroduces Bill to Establish National NIL Framework for Collegiate Athletes – On Wednesday, Septmeber 14, Senator Roger Wicker (R-MS) reintroduced the Collegiate Athlete Compensation Rights Act into the U.S. Senate. If enacted, the bill would codify name, image and likeness (NIL) rights for collegiate athletes into federal statute, prohibit the use of NIL compensation packages to recruit students to particular college sports programs and establish a uniform framework for the compensation of NIL rights at the federal level.

Centripetal Networks Asks SCOTUS to Reinstate $2.7 Billion Patent Verdict – On Tuesday, September 13, patent owner Centripetal Networks filed a petition for writ of certiorari with the U.S. Supreme Court asking the nation’s highest court to reverse the Federal Circuit’s determination that the district judge did not properly divest shares of Cisco stock before entering a ruling finding that Cisco infringed upon Centripetal’s patent claims. Centripetal argues that the judge’s deposit of the shares into a blind trust prior to entering the ruling satisfies the requirements of 28 U.S.C. § 455(f) governing recusal of judges in cases where the judge has a financial interest in the outcome.

New Vision and Amici Redouble Due Process Arguments After GAO Report – On Monday, September 12, inventor advocacy group US Inventor filed an amicus brief at the Federal Circuit supporting the recent appeal of the USPTO’s denial of Director review by New Vision Gaming, which contends that a recent report by the U.S. Government Accountability Office (GAO) on the USPTO’s control of administrative patent judges (APJs) at the PTAB lend sufficient weight to arguments that patent validity trials at the PTAB violate constitutional due process. Two days after US Inventor’s brief was filed, another amicus filing from engineer and patent policy commentator Ron Katznelson provided empirical data underscoring the pecuniary interest of APJs in America Invents Act (AIA) trials biasing those agency judges in favor of instituting AIA petitions.

Biden Issues Executive Order on Advancing Innovation in Biotech and Biomanufacturing – On Monday, September 12, President Joe Biden issued an executive order on advancing biotechnology and biomanufacturing innovation which directs the heads of several Executive Branch agencies to harness research and development efforts in those areas to support societal goals related to health, climate change, supply chains and more. On Wednesday, the White House released a fact sheet indicating that the Biden Administration would be appropriating $2 billion for the biotech and biomanufacturing initiative ahead of a summit with top Executive Branch officials to discuss the implementation of Biden’s executive order.

USPTO Extends Public Comment on Director Review, POP and Internal Process for PTAB Decisions – The United States Patent and Trademark Office (USPTO) announced on Monday, September 12, that it will be extending the deadline for its request for comments announced in July seeking public input on Director review, Precedential Opinion Panel (POP) review, and internal circulation and review of Patent Trial and Appeal Board (PTAB) decisions. The original deadline of September, 19, 2022, has been extended to October 19, 2022. The Request for Comments (RFC) is available in the Federal Register.


Vidal Tapped as Third Federal Co-Chair of NACIE – On Thursday, September 15, U.S. Secretary of Commerce Gina Raimondo announced that Kathi Vidal, currently the Director of the U.S. Patent and Trademark Office, has been named as the third Federal Co-Chair of the National Advisory Council on Innovation & Entrepreneurship (NACIE), which is responsible for developing a national entrepreneurship strategy and facilitating public-private dialogue for improving the U.S. innovation economy.

Novartis Confirms Investigation by Swiss Regulators Over Dermatology Patent – On Thursday, September 15, Swiss pharmaceutical firm Novartis announced that it had been contacted by the Swiss Competition Commission, known internationally as COMCO, regarding an investigation being conducted by that regulatory authority into Novartis’ patent litigation activities surrounding a patent covering a technology in the field of dermatology treatments.

Controversial Drug Patent Report Generator I-MAK Releases Drug Pricing Study – On Thursday, September 15, the Initiative for Medicines, Access & Knowledge (I-MAK), whose past data reports have created controversy among patent academics over questionable data analytics, released a new report accusing major drugmakers of gaming the patent system to maintain exorbitant price levels on brand-name consumer drugs.

CFC Finds U.S. Government Had Paid-Up License to Practice Transgenic Mice Patent – On Wednesday, September 14, the U.S. Court of Federal Claims unsealed the court’s recent decision in University of South Florida, Board of Trustees v. United States in which the court ruled that the U.S. government had an irrevocable, paid-up license to practice a USF patent covering a method of preparing transgenic mice with accelerated pathology for Alzheimer’s disease. The CFC found the paid-up license under 35 U.S.C. § 202(c)(4) after finding that the inventors developed the invention under government funding.

Mattel Settles Nicki Minaj “Barbie-Que” Chip Trademark Case – On Wednesday, September 14, toy maker Mattel filed a voluntary dismissal in the Central District of California following a reported settlement of Mattel’s trademark claims against Rap Snacks, which had marketed a Nicki Minaj-branded potato chip known as “Barbie-Que” before pulling that product from online stores following Mattel’s lawsuit filing in August.

Wegmans Faces Patent Suit Over In-App Coupon Distributions – On Tuesday, September 13, TV messaging tech developer Optinetix Israel filed a lawsuit in the Southern District of New York against grocery chain Wegmans Food Markets alleging claims of patent infringement based on Wegmans’ use of a mobile app to distribute coupons to consumers.

U.S. Chamber, CBP Announce Counterfeit Partnership With Sports Leagues – On Tuesday, September 13, the U.S. Chamber of Commerce and U.S. Customs and Border Protection (CBP) announced a partnership with Major League Baseball (MLB) and the National Basketball Association (NBA) to combat sales of counterfeit sports merchandise.

USITC Enters LEO, CDO in Section 337 Investigation Over Plant-Derived rHSA Imports – On Monday, September 12, the U.S. International Trade Commission (USITC) announced that the ageny had entered a limited exclusion order (LEO) and cease and desist order (CDO) against several entities accused of patent infringement by Kansas-based Ventria Bioscience over imports of plant-derived recombinant human serum albumins (rHSA) into the U.S. for sale.

Miley Cyrus Faces Another Copyright Suit Over Use of Photograph on Instagram – On Friday, September 9, American photographer Robert Barbera filed a lawsuit against pop star Miley Cyrus over a February 2021 post on Instagram by Cyrus in which she made an unauthorized use of a picture of herself that was captured by Barbera.

This Week on Wall Street

GM Announces $491M Investment in EV Upgrades at Marion, IN Plant – On Thursday, September 15, American automaker General Motors announced that it plans to invest $491 million into plant upgrades at its Marion Metal Center in Indiana, including new equipment for stamping steel and aluminum into parts for GM’s new generation of electric vehicles (EVs).

Adobe to Acquire Collaborative Design Firm Figma for in $20B Deal – On Thursday, September 15, cloud and document software firm Adobe announced that it had agreed to purchase Figma, developer of a web-first collaborative design and workflow platform, in a cash and stock deal valued at about $20 billion.

Quarterly Earnings – The following firms identified among the IPO’s Top 300 Patent Recipients for 2021 are announcing quarterly earnings next week (2020 rank in parentheses):

  • Monday: None
  • Tuesday: None
  • Wednesday: None
  • Thursday: Accenture plc (t-141st)
  • Friday: None

Image Source: Deposit Photos
Image ID: 220243566
Author KostyaKlimenko



Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.

Join the Discussion

One comment so far. Add my comment.

  • [Avatar for Pro Say]
    Pro Say
    September 16, 2022 04:17 pm




Add Comment

Your email address will not be published.